
|Articles|November 1, 2012
Cytokine response implicated in uropathogenic E. coli infection
Researchers at Northwestern University in Chicago are exploring the complex web woven by cytokines in uropathogenic Escherichia coli bladder infections and in so doing, are opening avenues for potential therapies for these infections.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Toni Choueiri, MD, reacts to FDA approval of adjuvant belzutifan with pembrolizumab for ccRCC
2
Dean Elterman, MD, highlights efficacy and safety data on the Zenflow Prostatic Spring
3
FDA approves capivasertib plus abiraterone and prednisone for PTEN-deficient mHSPC
4
The UroOnc Minute: Variant Histologies in Bladder Cancer, With Carissa Chu, MD
5











